Acadia Pharma (ACAD) Misses Q2 EPS by 6c

Acadia Pharma (NASDAQ: ACAD) reported Q2 EPS of ($0.39), $0.06 worse than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c